Habib Bennaceur: NNHF Strengthens Haemophilia and Haemoglobinopathy Care Worldwide
Habib Bennaceur, Senior Vice President of Rare Disease Unit at Novo Nordisk, shared Novo Nordisk Haemophilia and Haemoglobinopathies Foundation‘s post on LinkedIn:
“Since 2005, the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation (NNHF) has worked with local partners to strengthen care worldwide, supporting 265 projects across 88 countries to date.
In the first half of 2026, NNHF:
- Added five new projects to its global portfolio.
- Advanced its collaboration with Africa Centres for Disease Control and Prevention (Africa CDC) to support stronger policies, diagnosis and access to care across Africa.
- Strengthened local capacity, with 345+ healthcare professionals trained across India, Mozambique and Venezuela, alongside many more activities across countries and regions.
As President of the NNHF, I am proud to see this progress taking shape across our programmes.
To all NNHF partners, thank you for your ongoing commitment!
Discover more in the First-half 2026 Programme Report.”
Novo Nordisk Haemophilia and Haemoglobinopathies Foundation shared a post on LinkedIn:
“What does progress look like?
Progress takes many forms: improved diagnosis, stronger care systems, and knowledge and expertise shared across borders.
During the first half of 2026:
Stronger diagnosis and care
In Mozambique, more than 180 healthcare professionals, including laboratory technicians, received haemophilia training, helping strengthen diagnosis, referral pathways and access to multidisciplinary care closer to home for people living with haemophilia.
Stronger systems of care
In Nigeria, the Inherited Blood Disorders Leadership Forum brought together 74 stakeholders and led to the establishment of a Technical Working Group for sickle cell disease, haemophilia and other inherited blood disorders.
Knowledge and expertise shared across borders
Across East Africa, West Francophone Africa, Central America and the Caribbean, Portuguese-speaking Africa and the Vanilla Islands, partners are connecting within their regions to share expertise and strengthen approaches to care.
These examples are only a snapshot of the developments featured in our First-half 2026 Programme Report.”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support
-
Nov 17, 2026, 23:34Ahmed Bennis: Is Aspirin Therapy Enough for VTE Prevention After Arthroplasty?
-
Nov 17, 2026, 23:33Remi Remakanth: The Role of Transfusion Medicine in HLA Antibody Testing and Transplant Desensitization